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1. Introduction 
C22 monounsaturated fatty acids are abundant in 
some types of rapeseed oil and some marine oils used 
for human consumption i many countries. 
In feeding experiments rapeseed oil, rich in erucic 
acid (22:1, n-9cis) causes a fatty infiltration in the 
heart of rats and several other species [1 ]. 
Previous tudies with isolated heart and liver mito- 
chondria have shown that erucic acid is oxidized at a 
distinctly slower ate than palmitic acid. It has also 
been shown that erucic acid inhibits the oxidation of 
other fatty acids in mitochondria, probably by an 
inhibitory effect on acyl CoA dehydrogenase [2]. 
In vivo experiments with 14C-labelled erucic acid 
given to rats have shown that part of the injected 
radioactivity is recovered in shorter monounsaturated 
fatty acids, particularly in oleic acid in liver [3]. A 
chain shortening of erucic acid in cultured myocytes 
has also been reported [4]. 
In the present work the metabolism of erucic acid 
in isolated liver cells has been studied. 
2. Materials and methods 
[1-14C]Palmitic acid was obtained from the Radio- 
chemical Center, Amersham. [14-14C]Erucic acid 
(22:1, n-9cis) was from Centre d'Etudes Nucl6aires 
de Saclay, Gif sur Yvette. (-)-Carnitine chloride was 
from Koch-Light Labs Ltd, Colnbrook Bucks. Essen- 
tially fatty acid free bovine albumin, N-2 hydroxy- 
ethylpiperazine-N-2-ethanesulfonic acid (Hepes), 
collagenase Type I and erucic acid were from Sigma 
Chemical Co., St Louis, MO. Palmitic acid was from 
Fluca AG, Switzerland. 
Hepatocytes were prepared from livers of male 
Wistar-derived rats (220-250 g). The rats had free 
access to food and water until they were sacrified. 
Isolated hepatocytes were prepared and purified 
as in [5]. About 100-300 X 106 cells were obtained 
from each liver, and 90-95% were viable, measured 
as resistance to uptake of trypan blue. 
In most experiments the incubation medium was 
as in [6]. If not stated otherwise the fatty acid con- 
centration was 1 mM. In some experiment the hepa- 
tocytes were preincubated for 30 min with (-)-carni- 
tine as in [7]. 
The extraction of lipids, the measurements of 
radioactive acid-soluble products and radioactive CO2 
were performed as in [7]. 
The lipids were separated in silicic acid thin-layer 
plates (stahl H) (hexane-diethylether-glacial etic 
acid, 85:15:5, v/v/v). Aliquots of the totallipid extract 
and of the free fatty acid, triglyceride and phospho- 
lipid fractions were transmethylated [8] and analyzed 
by radio-gas chromatography using a Pye 104 gas 
chromatograph connected to a ESI Nuclear adio- 
activity detector with a 1 : 1 outlet splitter. Fatty acid 
methyl-esters were separated at 185°C using 10% 
SP-2340 on Supelcoport 100/120 (Supelco Inc., 
Bellefonte, PA). The peaks were identified on the 
basis of the retention time compared with the stan- 
dards. 
3. Results and discussion 
Table 1 shows that erucic acid is metabolized ata 
distinctly lower rate than palmitic acid in isolated liver 
cells. After 30 min incubation the total amount in 
moles of erucic acid, oxidized and esterified was only 
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30% of the amount metabolized with palmitic acid. 
The ratio of fatty acid oxidized above fatty acids 
incorporated in triacylglycerol seems to be approxi- 
mately the same for erucic acid and palmitic acid. 
The relative amounts of fatty acid channelled to 
oxidation and to triacylglycerol synthesis thus seems 
to be the same with both fatty acids. 
The addition of carnitine had little effect on the 
total amount of fatty acid metabolized both with 
erucic acid and with palmitic acid. Only a very slight 
stimulatory effect of carnitine was observed. 
It has previously been shown that addition of 
carnitine increased the rate of oxidation and reduced 
the esterification of palmitic acid in isolated liver cells 
[7]. 
Table 1 also shows that carnitine stimulates the 
oxidation and reduces the esterification oferucic acid 
to triacylglycerol. The effects of carnitine on the metab- 
olism of erucic acid seems to be slightly more pro- 
nounced than the effect on palmitic acid. It is further 
shown that the incorporation i to phospholipids i  
distinctly lower with erucic acid than with palrnitic 
acid. The effect of carnitine on the esterification to
phospholipids i  less marked than the effect on the 
triacylglycerol synthesis both with erucic acid and 
with palmitic acid. 
The possibility of a chain shortening of [14:4C]- 
erucic acid to other fatty acids was studied by using 
radio-gas chromatography. Figure 1A shows that 
significant amounts of the ~4C label appeared in oleic 
acid (18:1, n-9), eicosenoic acid (20:1, n-9) and in 
palmitoleic acid (I 6:1, n-9) after incubation of hepa- 
tocytes with 14C-labelled erucic acid. [14C]Oleic acid 
accumulated approximately twice as fast as [14C]eico- 
senoic acid. Only relatively small amounts of [14C]- 
palmitoleic acid were formed. After 120 min of incu- 
bation 15-20% of the radioactivity added as [ 14-14C]- 
erucic acid appeared inshorter fatty acids with approx. 
10% in oleic acid alone. 
Figure 1B shows that the rate of formation 
of [14C]eiCosenoic-, [14C]oleic-and [14C]palmitoleic 
acid increased with increasing concentrations of 
[14C]erucic acid in the incubation medium until a 
maximal rate of chain shortening was reached at approx. 
1 mM of erucic acid. 
Table 2 shows the content of different ~4C-labelled 
fatty acids in the triacylglycerol and phospholipid 
fractions from isolated hepatocytes incubated with 
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Fig. 1. Formation of [ t4C]oleic acid (18:1, n-9), [14C]eico- 
senoie acid (20:1, n-9) and [t4C]palmitoleic acid (16:1, n-9) 
from [14C]erucie acid in isolated liver cells. (A) Hepatoeytes 
(12.8 mg protein) were incubated with 1 mM erucic acid as 
described insection 2. (B) Hepatocytes (12.0 mg protein) 
were incubated with different concentrations of [~4Clerucic 
acid for 30 min. (m-.) oleie acid; (o-o) eicosenoie acid; 
(A--A) palmitoleic acid. 
[14C]erucic acid. In the triacylglycerol fraction the 
labelled C20:1, C18:1 and C16:1 fatty acids accounted 
for 40-50% of the radioactivity with the rest of the 
activity in erucic acid. In the phospholipid fraction 
75-85% of the radioactivitywas found in the shortened 
C20:1, C18:1 and C16:1 fatty acids. Erucic acid thus 
seems to be less readily incorporated in the phospho- 
lipid fraction than in triacylglycerol. 
These observations agree with the finding that very 
low density lipoproteins from rat livers perfused with 
[14C]erucic acid contain a high proportion of labelled 
C20:1, C18:1 and C16:1 fatty acids [10]. In the free 
fatty acid fraction only very small amounts of short- 
ened fatty acids were found as this fraction mainly 
consists of unmetabolized xtracellular e ucic acid 
substrate. 
The rapid chain shortening of erucic acid to C20:1, 
C18:1 and C16:1 fatty acids in isolated liver cells 
demonstrated in the present study, may occur either 
in the mitochondria orby an extramitochondrial/3 
oxidation system. In previous work with isolated liver 
and heart mitochondria with the carnitine ster of 
[laC]erucie acid as the substrate, we were unable to 
demonstrate any accumulation of radioactive C20:1 , 
C18:1 or C16:1 fatty acids in the medium (unpublished). 
It is interesting that an extramitochondrial/3 oxidation 
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Table 2 
Incorporation of shorter fatty acids formed from [ l*C]erucic acid in different lipid 
fractions of isolated liver cells - effect of carnitine 
Lipid fraction Incubation Sum C16:1 C18:1 C20:1 C22:1 
(min) 
Triglycerid 30 10.4 - 3.1 1.3 6.0 
Phospholipids 30 5.6 - 2.9 1.7 1.0 
FFA 30 93.2 - 1.3 0.3 91.6 a 
Triglycerides 60 15.0 0.6 4.4 2.9 7.1 
Phospholipids 60 8.8 0,2 3.9 3.2 1.5 
FFA 60 70.2 0.5 3.1 0.6 66.0 a 
Total lipid 
+ carnitine 120 1.2 14.2 6.4 55.3 b 
Total lipid 
- carnitine 120 1.5 17.2 8.3 62.9 b 
a Unmetabolized free erueic acid 
b Sum of esterified +unmetabolized free erucic acid 
Hepatocytes (12.4 mg protein) were incubated with 1 mM erucic acid as in section 2. 
The results are expressed as nmol [l*C]fatty acid in each fraction × mg protein -1 . 
Carnitine (4 mM) was added where indicated 
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of fatty acids has recently been found and localized 
to the peroxisomes [9]. 
If the accumulation of radioactive C20:1, C18:1 and 
C16:1 fatty acids observed with hepatocytes incubated 
with [14C]erucic acid should be caused by mitochon- 
drial/3 oxidation, it would mean that the labelled 
shortened fatty acids present in the triacylglycerol 
stems from erucic acid which had first been trans- 
ported into the mitochondria and then after a chain 
shortening had left the mitochondria for the extra- 
mitochondrial triacylglycerol synthesis. 
The stimulating effect of carnitine on the oxidation 
of erucic acid in liver cells, is most probably caused 
by an increased mitochondrial/~ oxidation. 
If the accumulation of C20:1, C18:1 and C16:1 fatty 
acids from [14C]erucic acid was caused by regular 
mitochondrial/3 oxidation, one should expect hat 
addition of carnitine would not significantly decrease 
the proportion of labelled C20:1 ,C18:1 and C16:1 fatty 
acids. 
The finding that carnitine reduces the content of 
C20.1, C18.1 and C16.1 fatty acids formed from 
[14C]erucic acid in isolated liver cells (table 2) there- 
fore suggest that the chain shortening occurs outside 
the mitochondria, possibly in the peroxisomes. This 
view is also supported by the finding [11 ] that the 
chain shortening of  erucic acid is increased in hepa- 
tocytes from rats fed chlofibrate. Chlofibrate is known 
to cause a proliferation of peroxisomes [9]. 
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